BMRN · Biomarin Pharmaceutical Inc

$67.36 -1.17 (-1.71%) At close · Aug 14

Market Cap

$13.04B

193.57M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2022-12-31	$0	—	—	10-K, filed 2023-02-27
2021-12-31	$0	—	—	10-K, filed 2023-02-27
2020-12-31	$50,000,000	—	—	10-K, filed 2023-02-27

2019-12-31	$0	—	—	10-K, filed 2022-02-25
2018-12-31	$0	—	—	10-K, filed 2021-02-26

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2021-12-31	$0 Δ	—	—	10-K, filed 2023-02-27
2021-09-30	$0 Δ	—	—	10-Q, filed 2021-10-29
2020-12-31	$0 Δ	—	—	10-K, filed 2023-02-27
2020-09-30	$0 Δ	—	—	10-Q, filed 2021-10-29
2019-12-31	$0 Δ	—	—	10-K, filed 2022-02-25
2019-09-30	$0 Δ	—	—	10-Q, filed 2020-11-06

Key facts CIK 1048477 CUSIP 09061G101 13F (30d) 543 filings 511 filers Visit website Investor relations